EBV is a member of the herpesvirus family, the same group responsible for chickenpox and cold sores. It spreads easily ...

The U.S. Food and Drug Administration (FDA) has approved Breyanzi (lisocabtagene maraleucel) for the treatment of adults with relapsed or refractory marginal zone lymphoma who have received at least ...

This story is part 3 in a four-part series about cell therapy created by the Fierce Biotech team. Part 1 is available here, part 2 is here and the final installment is here. Gabrielle Masson, Helen ...

Please provide your email address to receive an email when new articles are posted on . Last November, results from the MITIGATE trial made headlines at ACR Convergence 2024 with positive phase 3 ...

Findings represent a detailed resource for future research that could lead to the development of new biomarkers and targeted therapeutics for T1D.